奇正藏药(002287.SZ)发布前三季度业绩，归母净利润4.24亿元，同比增长7.66%

Core Viewpoint - Qizheng Tibetan Medicine (002287.SZ) reported a revenue of 1.523 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 3.48% [1] - The net profit attributable to shareholders of the listed company reached 424 million yuan, marking a year-on-year increase of 7.66% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 282 million yuan, with a year-on-year growth of 4.21% [1] Financial Performance - Revenue for the first three quarters: 1.523 billion yuan, up 3.48% year-on-year [1] - Net profit attributable to shareholders: 424 million yuan, up 7.66% year-on-year [1] - Net profit after deducting non-recurring gains and losses: 282 million yuan, up 4.21% year-on-year [1]